Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 109Leukemia, Myeloid, Acute 102Leukemia 97Myelodysplastic Syndromes 87Precursor Cell Lymphoblastic Leukemia-Lymphoma 74Lymphoma, Non-Hodgkin 71Lymphoma 71Multiple Myeloma 70Hodgkin Disease 68Lymphoma, Mantle-Cell 53Lymphoma, Follicular 51Lymphoma, Large B-Cell, Diffuse 50Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Lymphoma, B-Cell, Marginal Zone 44Myeloproliferative Disorders 43Congenital Abnormalities 41Burkitt Lymphoma 37Leukemia, Myelomonocytic, Chronic 36Waldenstrom Macroglobulinemia 32Leukemia, Myeloid, Accelerated Phase 32Primary Myelofibrosis 31Melanoma 31Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic-Phase 31Blast Crisis 28Recurrence 27Neoplasms, Plasma Cell 25Hematologic Neoplasms 24Lymphoma, T-Cell, Cutaneous 23Dendritic Cell Sarcoma, Interdigitating 23

Interventions

Cisplatin 4pembrolizumab 3Nivolumab 3Fluorouracil 2Carboplatin 2toripalimab 1spartalizumab 1fludarabine phosphate 1fludarabine 1cc-486 1camrelizumab 1Vorinostat 1Valganciclovir 1Range of Motion, Articular 1Radiotherapy 1Radiosurgery 1Protons 1Platinum 1Methylprednisolone 1Medicare Part B 1Laryngoscopes 1Gemcitabine 1Docetaxel 1Cyclophosphamide 1Cetuximab 1Bevacizumab 1Azacitidine 1Adrenal Cortex Hormones 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Nasopharyngeal Carcinoma × fludarabine phosphate × Clear all
NCT02287311 2026-03-23

MABEL

Baylor College of Medicine

Phase 1 Active not recruiting
38 enrolled 16 charts
Head & NeckLymphoid

Nasopharyngeal Carcinoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Smooth Muscle Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡